U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Recommended Clinical Study Design for Ventricular Tachycardia Ablation
  1. Regulatory Information

GUIDANCE DOCUMENT

Recommended Clinical Study Design for Ventricular Tachycardia Ablation May 1999

Final

Recommended Clinical Study Design for Ventricular Tachycardia Ablation

Issued by:
Guidance Issuing Office
Center for Devices and Radiological Health

The use of cardiac ablation for the treatment of Ventricular Tachycardia raises many new questions of safety and effectiveness in comparison to the use of cardiac ablation for the treatment of Supraventricular Tachycardias. The following outline has been provided to aid sponsors in developing a protocol for the treatment of Ventricular Tachycardia. We have given you two study designs: non-randomized and randomized. In no way is this outline intended to be all inclusive of the necessary components for a clinical study. This outline was based on recommendations provided to the FDA by Circulatory System Devices Panel members and by comments offered by clinical investigators.


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Division of Dockets Management (HFA- 305)
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.